FDA Label for Liquimat Acne Treatment And Cover-up
View Indications, Usage & Precautions
Liquimat Acne Treatment And Cover-up Product Label
The following document was submitted to the FDA by the labeler of this product Summers Laboratories Inc. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Otc - Active Ingredient
ACTIVE INGREDIENT
SULFUR 4%
Otc - Purpose
PURPOSE
ACNE TREATMENT LOTION
Indications & Usage
USE
DRIES UP ACNE PIMPLES, HELPS PREVENT NEW PIMPLES
Warnings
WARNINGS
- FOR EXTERNAL USE ONLY
Otc - Do Not Use
DO NOT USE
- ON BROKEN SKIN
- ON LARGE AREAS OF THE BODY
Otc - When Using
WHEN USING THIS PRODUCT
- APPLY TO AFFECTED AREAS ONLY
- DO NOT GET INTO EYES
- USING OTHER TOPICAL ACNE DRUGS AT THE SAME TIME OR RIGHT AFTER USE OF THIS PRODUCT MAY INCREASE DRYNESS OR IRRITATION OF THE SKIN. IF THIS OCCURS, ONLY ONE DRUG SHOULD BE USED UNLESS DIRECTED BY A DOCTOR
Otc - Stop Use
STOP USE AND ASK A DOCTOR IF
- TOO MUCH IRRITATION DEVELOPS OR INCREASES
Otc - Keep Out Of Reach Of Children
KEEP OUT OF REACH OF CHILDREN. IF SWALLOWED, GET MEDICAL HELP OR CONTACT A POISON CONTROL CENTER RIGHT AWAY.
Dosage & Administration
DIRECTIONS
- CLEAN SKIN THOROUGHLY BEFORE USING
- COVER THE ENTIRE AFFECTED AREA WITH A THIN LAYER 1 TO 3 TIMES DAILY
- BECAUSE TOO MUCH DRYING OF THE SKIN MAY OCCUR, START WITH 1 APPLICATION DAILY, THEN INCREASE TO 2 TO 3 TIMES DAILY IF NEEDED OR AS DIRECTED BY A DOCTOR.
Inactive Ingredient
INACTIVE INGREDIENTS
WATER, SD-40 ALCOHOL 22-PERCENT, KAOLIN, ZINC OXIDE, GLYCERIN, TITANIUM DIOXIDE, TALC, CELLULOSE GUM, MAGNESIUM ALUMINUM SILICATE, CETYL ALCOHOL, POLOXAMER 182, FRAGRANCE, IRON OXIDES. COLOR MATCHER CONTAINS IRON OXIDES, PEG-8, PEG-8 LAURATE, SIMETHICONE.
* Please review the disclaimer below.